These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26905067)

  • 1. Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests.
    Tardif KD; Pyne MT; Malmberg E; Lunt TC; Schlaberg R
    PLoS One; 2016; 11(2):e0149611. PubMed ID: 26905067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Performance of SurePath™ Preservative Compared to PreservCyt® with Cobas® and Hybrid Capture® 2 HPV Tests in a Colposcopy Population.
    Pyne MT; Tardif KD; Allen A; Sexsmith C; Lesher L; Adelman M; Janát-Amsbury MM; Schlaberg R
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative Fluid.
    Krevolin MD; Hardy D; Pane J; Aslam S; Behrens CM
    J Mol Diagn; 2017 Mar; 19(2):288-294. PubMed ID: 28041871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of cervical specimens in SurePath medium for human papillomavirus testing with the Roche cobas 4800 assay.
    Gilbert L; Oates E; Ratnam S
    J Clin Microbiol; 2013 Oct; 51(10):3412-4. PubMed ID: 23903540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
    Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
    J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison Study of BD Onclarity HPV With digene HC2 High-Risk HPV DNA Test and Roche Cobas 4800 HPV for Detecting High-Risk Human Papillomavirus in Japan.
    Nakamura M; Nakade K; Orisaka S; Iwadare J; Mizumoto Y; Fujiwara H
    Am J Clin Pathol; 2019 Feb; 151(3):263-269. PubMed ID: 30260388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
    Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
    Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.
    Binnicker MJ; Pritt BS; Duresko BJ; Espy MJ; Grys TE; Zarka MA; Kerr SE; Henry MR
    J Clin Microbiol; 2014 Oct; 52(10):3763-8. PubMed ID: 25122861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of cobas 4800 HPV assay in SurePath Papanicolaou specimens for cervical cancer screening.
    Guo M; Shlyakhova N; Khanna A; Tinnirello AA; Schmeler KM; Hwang J; Sturgis EM; Stewart J
    J Am Soc Cytopathol; 2021; 10(4):399-405. PubMed ID: 33967024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the cobas HPV Test for the Triage of Atypical Squamous Cells of Undetermined Significance Cytology in Cervical Specimens Collected in SurePath.
    Tewari D; Novak-Weekley S; Hong C; Aslam S; Behrens CM
    Am J Clin Pathol; 2017 Nov; 148(5):450-457. PubMed ID: 29045515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition from Hybrid Capture 2 to Cobas 4800 in Hpv detection: sensitivity and specificity for Cin2+ in two time periods.
    Bottari F; Boveri S; Iacobone AD; Gulmini C; Igidbashian S; Cassatella MC; Landoni F; Sandri MT
    Infect Dis (Lond); 2018 Jul; 50(7):554-559. PubMed ID: 29463149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SurePath Specimens Versus ThinPrep Specimen Types on the COBAS 4800 Platform: High-Risk HPV Status and Cytology Correlation in an Ethnically Diverse Bronx Population.
    Naeem RC; Goldstein DY; Einstein MH; Ramos Rivera G; Schlesinger K; Khader SN; Suhrland M; Fox AS
    Lab Med; 2017 Aug; 48(3):207-213. PubMed ID: 28379422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework.
    Ejegod DM; Hansen M; Christiansen IK; Pedersen H; Quint W; Xu L; Arbyn M; Bonde J
    J Clin Virol; 2020 Jul; 128():104336. PubMed ID: 32446166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
    Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
    J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance of the BD Onclarity HPV assay using an adjudicated cohort of BD SurePath liquid-based cytology specimens.
    Wright TC; Stoler MH; Agreda PM; Beitman GH; Gutierrez EC; Harris JM; Koch KR; Kuebler M; LaViers WD; Legendre BL; Leitch SV; Maus CE; McMillian RA; Nussbaumer WA; Palmer ML; Porter MJ; Richart GA; Schwab RJ; Vaughan LM
    Am J Clin Pathol; 2014 Jul; 142(1):43-50. PubMed ID: 24926084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Abbott RealTime High Risk HPV test: comparative evaluation of analytical specificity and clinical sensitivity for cervical carcinoma and CIN 3 lesions with the Hybrid Capture 2 HPV DNA test.
    Poljak M; Kovanda A; Kocjan BJ; Seme K; Jancar N; Vrtacnik-Bokal E
    Acta Dermatovenerol Alp Pannonica Adriat; 2009 Sep; 18(3):94-103. PubMed ID: 19784522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.
    Levi AW; Bernstein JI; Hui P; Duch K; Schofield K; Chhieng DC
    Arch Pathol Lab Med; 2016 Feb; 140(2):153-7. PubMed ID: 26910220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test performance comparison of inform HPV and hybrid capture 2 high-risk HPV DNA tests using the SurePath liquid-based Pap test as the collection method.
    Davis-Devine S; Day SJ; Freund GG
    Am J Clin Pathol; 2005 Jul; 124(1):24-30. PubMed ID: 15923167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
    Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.